Product Description
This digital document is an article from Dermatology Nursing, published by Thomson Gale on June 1, 2007. The length of the article is 3006 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the author: Pemphigus vulgaris is a chronic blistering disease. Clinically it is characterized by painful intra-epidermal bullae and superficial vesicles involving both the skin and mucosal areas. The diagnosis is confirmed by a skin biopsy along with immunofluorescence studies. Detection of circulating autoantibodies in the sera of patients, utilizing the ELISA technique, aids in the diagnosis of pemphigus vulgaris. Severity index and therapeutic guidelines have been developed and used for the proper management of the disease. The therapeutic armamentarium for this chronic blistering disease continues to extend with the addition of new agents and the use of different forms of combinations.

Citation Details
Title: Pemphigus vulgaris: a short review for the practitioner.(Disease Management)
Author: Sabrina Guillen
Publication: Dermatology Nursing (Magazine/Journal)
Date: June 1, 2007
Publisher: Thomson Gale
Volume: 19Issue: 3Page: 269(4)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Journal of Drugs in Dermatology, published by Thomson Gale on February 1, 2007. The length of the article is 993 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Searching for a safe and effective therapy for pemphigus vulgaris--the rituximab IVIg combination.(WASHINGTON WHISPERS)
Author: Isaac Brownell
Publication: Journal of Drugs in Dermatology (Magazine/Journal)
Date: February 1, 2007
Publisher: Thomson Gale
Volume: 6Issue: 2Page: 227(2)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Journal of Drugs in Dermatology, published by Journal of Drugs in Dermatology, Inc. on June 1, 2009. The length of the article is 314 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Randomized trial of IVIg with or without cyclophosphamide in pemphigus.(IMMUNOBULLOUS DISORDERS)(Brief article)
Author: Unavailable
Publication: Journal of Drugs in Dermatology (Magazine/Journal)
Date: June 1, 2009
Publisher: Journal of Drugs in Dermatology, Inc.
Volume: 8Issue: 6Page: 599(1)

Article Type: Brief article

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
This digital document is an article from Journal of Drugs in Dermatology, published by Journal of Drugs in Dermatology, Inc. on September 1, 2004. The length of the article is 566 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Practice pearl: gargling with cholinergic ophthalmic drops for treating the oral lesions of pemphigus vulgaris.(LETTERS TO THE EDITOR)
Author: M.R. Namazi
Publication: Journal of Drugs in Dermatology (Refereed)
Date: September 1, 2004
Publisher: Journal of Drugs in Dermatology, Inc.
Volume: 3Issue: 5Page: 484(2)

Distributed by Thomson Gale ... Read more

Product Description
This Book Is In German. ... Read more

Product Description
This digital document is an article from Skin & Allergy News, published by International Medical News Group on May 1, 2002. The length of the article is 712 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Experimental treatments promising for pemphigus. (Refractory Disease).(Brief Article)
Author: Kathryn DeMott
Publication: Skin & Allergy News (Magazine/Journal)
Date: May 1, 2002
Publisher: International Medical News Group
Volume: 33Issue: 5Page: 30(1)

Article Type: Brief Article

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2008. The length of the article is 491 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Cytotoxin boosts IVIG's efficacy for pemphigus.(News)
Author: Bruce Jancin
Publication: Skin & Allergy News (Magazine/Journal)
Date: August 1, 2008
Publisher: International Medical News Group
Volume: 39Issue: 8Page: 14(1)

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
This digital document is an article from Southern Medical Journal, published by Southern Medical Association on July 1, 2001. The length of the article is 3188 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Pemphigus in the Southeastern United States.
Author: Seniat Woldegiorgis
Publication: Southern Medical Journal (Refereed)
Date: July 1, 2001
Publisher: Southern Medical Association
Volume: 94Issue: 7Page: 694

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Skin & Allergy News, published by Thomson Gale on November 1, 2006. The length of the article is 1020 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Rituximab effective in difficult pemphigus cases.(Dermatologic Therapy)
Author: Kerri Wachter
Publication: Skin & Allergy News (Magazine/Journal)
Date: November 1, 2006
Publisher: Thomson Gale
Volume: 37Issue: 11Page: 20(2)

Distributed by Thomson Gale ... Read more

Product Description
This is an EXACT reproduction of a book published before 1923. This IS NOT an OCR'd book with strange characters, introduced typographical errors, and jumbled words.This book may have occasional imperfections such as missing or blurred pages, poor pictures, errant marks, etc. that were either part of the original artifact, or were introduced by the scanning process. We believe this work is culturally important, and despite the imperfections, have elected to bring it back into print as part of our continuing commitment to the preservation of printed works worldwide. We appreciate your understanding of the imperfections in the preservation process, and hope you enjoy this valuable book. ... Read more

Product Description
This Book Is In German. ... Read more

Product Description
Pemphigus vulgaris (PV) ist eine schwere, potentiell lebensbedrohliche Autoimmunerkrankung der Haut und/oder Schleimhäute. IgG-Autoantikörper gegen desmosomale Zelladhäsionsstrukturen sind die Ursache für die Akantholyse epidermaler Keratinozyten, die sich klinisch im Auftreten schlaffer, dünnwandiger Blasen und krustöser, schmerzhafter Erosionen an der Haut und den Schleimhäuten manifestiert. B-Lymphozyten besitzen in der Entstehung und Progression des PV eine fundamentale Bedeutung. Daher ist der Einsatz B-Zell-depletierender Medikamente, wie z.B. des monoklonalen anti-CD20 Antikörpers Rituximab, ein vielversprechender therapeutischer Ansatz in der Behandlung des PV. Das Verständnis der in dieser Arbeit näher charakterisierten Wirkung von Rituximab auf die zelluläre und humorale (Auto)Immunantwort ist ein weiterer wichtiger Schritt in der Aufklärung des genauen pathogenetischen Mechanismus, der dieser Autoimmunerkrankung zugrunde liegt. ... Read more

Product Description
This digital document is an article from Skin & Allergy News, published by Thomson Gale on November 1, 2007. The length of the article is 425 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: HLA typing identifies pemphigus risk factors.(News)
Author: Bruce Jancin
Publication: Skin & Allergy News (Magazine/Journal)
Date: November 1, 2007
Publisher: Thomson Gale
Volume: 38Issue: 11Page: 15(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Skin & Allergy News, published by Thomson Gale on November 1, 2007. The length of the article is 785 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Rituximab helps to uncover pemphigus origin.(News)
Author: Bruce Jancin
Publication: Skin & Allergy News (Magazine/Journal)
Date: November 1, 2007
Publisher: Thomson Gale
Volume: 38Issue: 11Page: 14(2)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Skin & Allergy News, published by International Medical News Group on November 1, 2009. The length of the article is 572 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Combination therapy is 'cheap,' 'effective' for pemphigus.(NEWS)
Author: Bruce Jancin
Publication: Skin & Allergy News (Magazine/Journal)
Date: November 1, 2009
Publisher: International Medical News Group
Volume: 40Issue: 11Page: 9(1)

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
This digital document is an article from Southern Medical Journal, published by Southern Medical Association on June 1, 2003. The length of the article is 1207 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Pemphigus vulgaris: an acquired blistering disease. (Case Report).
Author: Kirby J. Scott
Publication: Southern Medical Journal (Refereed)
Date: June 1, 2003
Publisher: Southern Medical Association
Volume: 96Issue: 6Page: 618(3)

Distributed by Thomson Gale ... Read more

Product Description
Purchase includes free access to book updates online and a free trial membership in the publisher's book club where you can select from more than a million books without charge. Chapters: Pemphigus, Dermatitis Herpetiformis, Grover's Disease, Bullous Pemphigoid, Cicatricial Pemphigoid, Pemphigus Vulgaris, Pemphigoid, Pemphigus Foliaceus, Linear Iga Bullous Dermatosis, Paraneoplastic Pemphigus, Endemic Pemphigus, Localized Cicatricial Pemphigoid, Pemphigus Erythematosus, Adult Linear Iga Disease, Childhood Linear Iga Disease, Intraepidermal Neutrophilic Iga Dermatosis, Vesicular Pemphigoid, Epidermolysis Bullosa Acquisita, Vulvar Childhood Pemphigoid, Pemphigoid Nodularis, Pemphigus Vegetans of Neumann, Pemphigus Vegetans of Hallopeau, Pemphigus Vegetans, Brunsting-perry Cicatricial Pemphigoid, Fogo Selvagem, Linear Immunoglobulin a Dermatosis, Chronic Bullous Disease of Childhood, Duhring Disease, Senear-usher Syndrome, Benign Mucosal Pemphigoid, Benign Mucous Membrane Pemphigoid, Mucous Membrane Pemphigoid, Ocular Pemphigus, Endemic Pemphigus Foliaceus, Transient Acantholytic Dermatosis. Excerpt:Adult linear IgA disease is an acquired, autoimmune blistering disease that may present with a clinical pattern of vesicles indistinguishable from dermatitis herpetiformis, or with vesicles and bullae in a bullous pemphigoid-like appearance. See also (online edition) References (URLs online) A hyperlinked version of this chapter is at Cicatricial pemphigoid Cicatricial pemphigoid (also known as "Benign mucosal pemphigoid," "Benign mucous membrane pemphigoid," "Ocular pemphigus," and "Scarring pemphigoid" ) is a rare chronic autoimmune subepithelial blistering disease characterized by erosive skin lesions of the mucous membranes and skin that results in scarring of at least some sites of involvement. :581 Cicatricial pemphigoid has been referred to by a variety of designations based largely on its site of involvements, with examples of such terminology including "desqua... ... Read more

Product Description
Depuis plus d'une décennie, le rôle de l'autoantigène lui-mêmedans l'initiation, la propagation et la pérennisation de la réponseautoimmune a été conforté par de nombreux argumentsexpérimentaux. En nous appuyant sur ce concept, nous avonsentrepris d'étudier l'intervention de la desmogléine 1 dans lesmécanismes physiopathologiques qui concourent au développementdes pemphigus. Les pemphigus sont des maladies autoimmunesspécifiques d'organe qui affectent la peau et les muqueuses. Ils sontcaractérisés par la production d'autoanticorps pathogènes dirigéscontre des protéines du desmosome, plus particulièrement, lesdesmogléines qui permettent l'adhésion entre eux des kératinocytesde l'épiderme. La desmogléine 1 est la cible majeure de laréponse autoimmune au cours des pemphigus dits "superficiels",mais aussi d'autres formes de pemphigus et par conséquent, semblejouer un rôle clé dans ces maladies. ... Read more